CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party.

IF 4.5 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2025-05-15 DOI:10.1038/s41409-025-02623-0

Nina Worel, Jarl E Mooyaart, Jorinde D Hoogenboom, Michael Daskalakis, Jean-Jacques Tudesq, Ron Ram, Vladan Vucinic, Stefania Bramanti, Lucía López Corral, Emma Nicholson, Robert Zeiser, Friedrich Stölzel, Eugenio Galli, Simona Pagliuca, Eva Wagner-Drouet, Friso Calkoen, Christian Chabannon, Florent Malard, Annalisa Ruggeri, Jürgen Kuball

引用次数: 0

查看原文本刊更多论文

现实世界中CAR-T细胞制造失败和不合规格的产品：EBMT细胞治疗和免疫生物学工作组的一项调查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.